DNA Damage/DNA Repair
- MTH1(4)
- PARP(66)
- ATM/ATR(22)
- DNA Alkylating(11)
- DNA Ligases(3)
- DNA Methyltransferase(19)
- DNA-PK(27)
- HDAC(119)
- Nucleoside Antimetabolite/Analogue(73)
- Telomerase(11)
- Topoisomerase(90)
- tankyrase(5)
- Antifolate(23)
- CDK(150)
- Checkpoint Kinase (Chk)(21)
- CRISPR/Cas9(7)
- Deubiquitinase(33)
- DNA Alkylator/Crosslinker(44)
- DNA/RNA Synthesis(141)
- Eukaryotic Initiation Factor (eIF)(11)
- IRE1(16)
- LIM Kinase (LIMK)(5)
- TOPK(4)
- Casein Kinase(25)
- DNA Intercalating Agents(0)
- DNA/RNA Oxidative Damage(0)
- Cat.No. Product Name Information
-
GC31365
γ-Oryzanol
-
GC38194
(±)-10-Hydroxycamptothecin
-
GC33107
(±)-BAY-1251152
-
GC10867
(+)-Aphidicolin
Tetracyclic diterpene antibiotic
-
GC32429
(-)-BAY-1251152
-
GC38377
(2S,3R)-Voruciclib hydrochloride
-
GC41716
(R)-CR8
Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising targets for cancer therapy.
-
GC34124
(rel)-MC180295
-
GC10098
(S)-10-Hydroxycamptothecin
inhibitor of topoisomerase I
-
GC34999
(S)-Ceralasertib
-
GC13136
(S)-Crizotinib
Potent MTH1 inhibitor
-
GC42061
2',3'-Dideoxyadenosine 5'-triphosphate
2',3'-Dideoxyadenosine 5'-triphosphate (ddATP) is an in vitro inhibitor of reverse transcriptases from retroviruses, including HIV-1 and visna (Kis = 20 and 37 nM, respectively).
-
GC33430
2'-Deoxypseudoisocytidine
-
GC33496
2-(Methylamino)-1H-purin-6(7H)-one (N2-methylguanine)
-
GC35105
3'-Azido-3'-deoxy-beta-L-uridine
-
GC34384
3,6-DMAD hydrochloride
-
GC34452
3,7,4'-Trihydroxyflavone
-
GC13510
3-AP
ribonucleotide reductase inhibitor and iron chelator with antitumor activity
-
GC15389
360A
G-quadruplex structures inhibitor
-
GC10115
360A iodide
G-quadruplex structures inhibitor
